HEADER RNA BINDING PROTEIN 18-NOV-09 3KRM TITLE IMP1 KH34 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR 2 MRNA-BINDING PROTEIN 1; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: RESIDUES 404-566; COMPND 5 SYNONYM: IGF2 MRNA-BINDING PROTEIN 1, IMP-1, IGF-II MRNA-BINDING COMPND 6 PROTEIN 1, CODING REGION DETERMINANT-BINDING PROTEIN, CRD-BP, VICKZ COMPND 7 FAMILY MEMBER 1, ZIP CODE-BINDING PROTEIN 1, ZIPCODE-BINDING PROTEIN COMPND 8 1, ZBP-1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGF2BP1, CRDBP, VICKZ1, ZBP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 KEYWDS RNA BINDING PROTEIN, KH DOMAIN, CELL PROJECTION, CYTOPLASM, NUCLEUS, KEYWDS 2 PHOSPHOPROTEIN, RNA-BINDING, TRANSLATION REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR J.A.CHAO,R.H.SINGER,S.C.ALMO,Y.PATSKOVSKY REVDAT 4 21-FEB-24 3KRM 1 REMARK REVDAT 3 25-OCT-17 3KRM 1 REMARK REVDAT 2 23-FEB-10 3KRM 1 JRNL REVDAT 1 09-FEB-10 3KRM 0 JRNL AUTH J.A.CHAO,Y.PATSKOVSKY,V.PATEL,M.LEVY,S.C.ALMO,R.H.SINGER JRNL TITL ZBP1 RECOGNITION OF BETA-ACTIN ZIPCODE INDUCES RNA LOOPING. JRNL REF GENES DEV. V. 24 148 2010 JRNL REFN ISSN 0890-9369 JRNL PMID 20080952 JRNL DOI 10.1101/GAD.1862910 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 5.1 REMARK 3 NUMBER OF REFLECTIONS : 20304 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1043 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 NULL REMARK 3 ANGLE : 1.227 NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3KRM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-DEC-09. REMARK 100 THE DEPOSITION ID IS D_1000056360. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20824 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 53.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.700 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.90 REMARK 200 R MERGE FOR SHELL (I) : 0.80600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.65M AMMONIUM CITRATE, 100MM TRIS, PH REMARK 280 7.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.73333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.86667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.80000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 21.93333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 109.66667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: GEL FILTRATION DATA THAT SHOW THE PROTEIN IS MONOMERIC IN REMARK 300 SOLUTION REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 1 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 -21.93333 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -21.93333 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 404 REMARK 465 GLN A 563 REMARK 465 HIS A 564 REMARK 465 GLN A 565 REMARK 465 LYS A 566 REMARK 465 GLU B 404 REMARK 465 PRO B 482 REMARK 465 LYS B 483 REMARK 465 GLN B 563 REMARK 465 HIS B 564 REMARK 465 GLN B 565 REMARK 465 LYS B 566 REMARK 465 GLU C 404 REMARK 465 LYS C 483 REMARK 465 GLN C 563 REMARK 465 HIS C 564 REMARK 465 GLN C 565 REMARK 465 LYS C 566 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 450 CG CD CE NZ REMARK 470 LYS B 450 CG CD CE NZ REMARK 470 LYS C 450 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 448 37.21 -98.74 REMARK 500 LYS A 483 46.37 -96.05 REMARK 500 PRO A 495 121.88 -39.02 REMARK 500 LYS B 423 97.97 -66.67 REMARK 500 LYS B 424 15.55 93.18 REMARK 500 PRO B 495 123.29 -35.40 REMARK 500 ASP B 526 63.78 71.35 REMARK 500 ASP B 530 -176.15 -54.47 REMARK 500 LYS C 423 108.21 -50.99 REMARK 500 GLN C 426 -71.13 -64.71 REMARK 500 PHE C 434 -74.71 -40.34 REMARK 500 PRO C 495 122.31 -38.77 REMARK 500 ASP C 526 65.43 76.56 REMARK 500 ASP C 530 178.41 -45.11 REMARK 500 ASN C 532 31.72 -81.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 4 DBREF 3KRM A 404 566 UNP Q9NZI8 IF2B1_HUMAN 404 566 DBREF 3KRM B 404 566 UNP Q9NZI8 IF2B1_HUMAN 404 566 DBREF 3KRM C 404 566 UNP Q9NZI8 IF2B1_HUMAN 404 566 SEQRES 1 A 163 GLU GLN GLU MET VAL GLN VAL PHE ILE PRO ALA GLN ALA SEQRES 2 A 163 VAL GLY ALA ILE ILE GLY LYS LYS GLY GLN HIS ILE LYS SEQRES 3 A 163 GLN LEU SER ARG PHE ALA SER ALA SER ILE LYS ILE ALA SEQRES 4 A 163 PRO PRO GLU THR PRO ASP SER LYS VAL ARG MET VAL ILE SEQRES 5 A 163 ILE THR GLY PRO PRO GLU ALA GLN PHE LYS ALA GLN GLY SEQRES 6 A 163 ARG ILE TYR GLY LYS LEU LYS GLU GLU ASN PHE PHE GLY SEQRES 7 A 163 PRO LYS GLU GLU VAL LYS LEU GLU THR HIS ILE ARG VAL SEQRES 8 A 163 PRO ALA SER ALA ALA GLY ARG VAL ILE GLY LYS GLY GLY SEQRES 9 A 163 LYS THR VAL ASN GLU LEU GLN ASN LEU THR ALA ALA GLU SEQRES 10 A 163 VAL VAL VAL PRO ARG ASP GLN THR PRO ASP GLU ASN ASP SEQRES 11 A 163 GLN VAL ILE VAL LYS ILE ILE GLY HIS PHE TYR ALA SER SEQRES 12 A 163 GLN MET ALA GLN ARG LYS ILE ARG ASP ILE LEU ALA GLN SEQRES 13 A 163 VAL LYS GLN GLN HIS GLN LYS SEQRES 1 B 163 GLU GLN GLU MET VAL GLN VAL PHE ILE PRO ALA GLN ALA SEQRES 2 B 163 VAL GLY ALA ILE ILE GLY LYS LYS GLY GLN HIS ILE LYS SEQRES 3 B 163 GLN LEU SER ARG PHE ALA SER ALA SER ILE LYS ILE ALA SEQRES 4 B 163 PRO PRO GLU THR PRO ASP SER LYS VAL ARG MET VAL ILE SEQRES 5 B 163 ILE THR GLY PRO PRO GLU ALA GLN PHE LYS ALA GLN GLY SEQRES 6 B 163 ARG ILE TYR GLY LYS LEU LYS GLU GLU ASN PHE PHE GLY SEQRES 7 B 163 PRO LYS GLU GLU VAL LYS LEU GLU THR HIS ILE ARG VAL SEQRES 8 B 163 PRO ALA SER ALA ALA GLY ARG VAL ILE GLY LYS GLY GLY SEQRES 9 B 163 LYS THR VAL ASN GLU LEU GLN ASN LEU THR ALA ALA GLU SEQRES 10 B 163 VAL VAL VAL PRO ARG ASP GLN THR PRO ASP GLU ASN ASP SEQRES 11 B 163 GLN VAL ILE VAL LYS ILE ILE GLY HIS PHE TYR ALA SER SEQRES 12 B 163 GLN MET ALA GLN ARG LYS ILE ARG ASP ILE LEU ALA GLN SEQRES 13 B 163 VAL LYS GLN GLN HIS GLN LYS SEQRES 1 C 163 GLU GLN GLU MET VAL GLN VAL PHE ILE PRO ALA GLN ALA SEQRES 2 C 163 VAL GLY ALA ILE ILE GLY LYS LYS GLY GLN HIS ILE LYS SEQRES 3 C 163 GLN LEU SER ARG PHE ALA SER ALA SER ILE LYS ILE ALA SEQRES 4 C 163 PRO PRO GLU THR PRO ASP SER LYS VAL ARG MET VAL ILE SEQRES 5 C 163 ILE THR GLY PRO PRO GLU ALA GLN PHE LYS ALA GLN GLY SEQRES 6 C 163 ARG ILE TYR GLY LYS LEU LYS GLU GLU ASN PHE PHE GLY SEQRES 7 C 163 PRO LYS GLU GLU VAL LYS LEU GLU THR HIS ILE ARG VAL SEQRES 8 C 163 PRO ALA SER ALA ALA GLY ARG VAL ILE GLY LYS GLY GLY SEQRES 9 C 163 LYS THR VAL ASN GLU LEU GLN ASN LEU THR ALA ALA GLU SEQRES 10 C 163 VAL VAL VAL PRO ARG ASP GLN THR PRO ASP GLU ASN ASP SEQRES 11 C 163 GLN VAL ILE VAL LYS ILE ILE GLY HIS PHE TYR ALA SER SEQRES 12 C 163 GLN MET ALA GLN ARG LYS ILE ARG ASP ILE LEU ALA GLN SEQRES 13 C 163 VAL LYS GLN GLN HIS GLN LYS HET GOL A 2 6 HET GOL A 4 6 HET GOL B 1 6 HET GOL B 3 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 GOL 4(C3 H8 O3) HELIX 1 1 ALA A 416 GLY A 422 1 7 HELIX 2 2 GLY A 425 SER A 436 1 12 HELIX 3 3 PRO A 459 GLU A 477 1 19 HELIX 4 4 ALA A 498 GLY A 504 1 7 HELIX 5 5 GLY A 507 ALA A 518 1 12 HELIX 6 6 HIS A 542 LYS A 561 1 20 HELIX 7 7 ALA B 416 GLY B 422 1 7 HELIX 8 8 GLY B 425 ALA B 435 1 11 HELIX 9 9 PRO B 459 GLU B 477 1 19 HELIX 10 10 ALA B 498 GLY B 504 1 7 HELIX 11 11 GLY B 507 ALA B 518 1 12 HELIX 12 12 HIS B 542 LYS B 561 1 20 HELIX 13 13 ALA C 416 GLY C 422 1 7 HELIX 14 14 GLY C 425 SER C 436 1 12 HELIX 15 15 PRO C 459 GLU C 477 1 19 HELIX 16 16 ALA C 498 GLY C 504 1 7 HELIX 17 17 GLY C 507 ALA C 518 1 12 HELIX 18 18 HIS C 542 LYS C 561 1 20 SHEET 1 A 6 SER A 438 ILE A 441 0 SHEET 2 A 6 VAL A 451 GLY A 458 -1 O ILE A 455 N LYS A 440 SHEET 3 A 6 GLU A 406 PRO A 413 -1 N VAL A 410 O VAL A 454 SHEET 4 A 6 LEU A 488 PRO A 495 -1 O GLU A 489 N PHE A 411 SHEET 5 A 6 GLN A 534 GLY A 541 -1 O VAL A 535 N VAL A 494 SHEET 6 A 6 GLU A 520 VAL A 522 -1 N GLU A 520 O ILE A 540 SHEET 1 B 6 SER B 438 ILE B 441 0 SHEET 2 B 6 VAL B 451 GLY B 458 -1 O ILE B 455 N LYS B 440 SHEET 3 B 6 GLU B 406 PRO B 413 -1 N VAL B 410 O VAL B 454 SHEET 4 B 6 LEU B 488 PRO B 495 -1 O HIS B 491 N GLN B 409 SHEET 5 B 6 GLN B 534 GLY B 541 -1 O VAL B 535 N VAL B 494 SHEET 6 B 6 GLU B 520 VAL B 522 -1 N GLU B 520 O ILE B 540 SHEET 1 C 6 SER C 438 ILE C 441 0 SHEET 2 C 6 VAL C 451 GLY C 458 -1 O ILE C 455 N LYS C 440 SHEET 3 C 6 GLU C 406 PRO C 413 -1 N VAL C 410 O VAL C 454 SHEET 4 C 6 LEU C 488 PRO C 495 -1 O GLU C 489 N PHE C 411 SHEET 5 C 6 GLN C 534 GLY C 541 -1 O VAL C 535 N VAL C 494 SHEET 6 C 6 GLU C 520 VAL C 522 -1 N GLU C 520 O ILE C 540 CISPEP 1 GLY A 481 PRO A 482 0 -14.65 CISPEP 2 GLY C 481 PRO C 482 0 -14.51 SITE 1 AC1 5 TYR A 544 GLU B 406 GLN B 547 ARG B 551 SITE 2 AC1 5 ARG B 554 SITE 1 AC2 4 VAL A 451 GLU A 489 HIS A 491 GLU C 445 SITE 1 AC3 4 PHE B 411 VAL B 451 GLU B 489 HIS B 491 SITE 1 AC4 4 GLY A 468 TYR A 471 TYR A 544 PHE B 464 CRYST1 103.530 103.530 131.600 90.00 90.00 120.00 P 65 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009659 0.005577 0.000000 0.00000 SCALE2 0.000000 0.011153 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007599 0.00000